Natus Medical Total Debt

Natus Medical Incorporated -- USA Stock  

USD 32.95  0.40  1.20%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Total Debt Analysis

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
Natus Medical 
Total Debt 
154.28 M

Distress Driver Correlations

 Natus Medical Total Debt 

About Total Debt

In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Natus Medical Total Debt Assessment


Natus Medical Debt Growth Over Time

Debt Current

Based on latest financial disclosure Natus Medical Incorporated has Total Debt of 154.28 M. This is 93.57% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Total Debt for all stocks is 97.9% higher than the company.

Peer Comparison

Natus Medical Total Debt Comparison
  Total Debt 
      Natus Medical Comparables 
Natus Medical is currently under evaluation in total debt category among related companies.

Did you try this?

Run Portfolio Backtesting Now

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
Hide  View All  NextLaunch Portfolio Backtesting